Sangamo presents IL23R-CAR-Tregs for treating Crohn's disease | SGMO Message Board Posts


Sangamo Therapeutics, Inc.

  SGMO website


  • We have set up a new board (#AdminHowTo) to better assist you with using our service and getting the most out of it.

    To access the board, click the blue link above or, if you are a registered member, you can check the latest message from Admin in your IV Inbox and click the link provided there as well.  

SGMO   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message    Post Message    Post a Reply return to message boardtop of board
Msg  160945 of 162059  at  10/27/2021 2:29:27 PM  by

gomasna

The following message was updated on 10/27/2021 2:31:12 PM.

 In response to msg 160943 by  JamieSoftware
view thread

Re: Sangamo presents IL23R-CAR-Tregs for treating Crohn's disease

You make a strong case for partnering, especially for the large indications.
 
But I also understand why Sangamo has taken it very slow on beta thal. Instead of going forward with inconsistent cell processing tech and uneven product, they have probably been perfecting the process behind the scenes. By doing that, Sangamo avoided the inevitable share price plunge that comes with disappointing bottom line clinical trial results. Instead, Sangamo/Sanofi now have the opportunity to surprise the markets to the upside with what has hopefully been going on behind the curtain. Fabry just seems plain old SLOW for no other reason than slow recruiting due to COVID.
 
We should be seeing a PR after markets close today announcing Q3 conference call. 
 
 
 


     e-mail to a friend      printer-friendly     add to library      
|  
Recs: 11  
   Views: 0 []
Previous Message  Next Message    Post Message    Post a Reply return to message boardtop of board


Financial Market Data provided by
.
Loading...